Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy.

Abstract

A trial of antepartum dexamethasone therapy was carried out in 55 mothers in whom premature delivery threatned between 28 to 36 weeks gestation in the hope of reducing the incidence of respiratory distress syndromes (RDS). The control group was made up of 62 mothers who delivered prematurely in the same gestational age without any treatment. In the treated… (More)

Topics

Cite this paper

@article{Caspi1976PreventionOT, title={Prevention of the respiratory distress syndrome in premature infants by antepartum glucocorticoid therapy.}, author={Eylon Caspi and Peter Schreyer and Zvi Weinraub and Rebecca Reif and Idan Levi and G. Mundel}, journal={British journal of obstetrics and gynaecology}, year={1976}, volume={83 3}, pages={187-93} }